Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ACURX PHARMACEUTICALS INC (ACXP)

17 + Investors. Track Smart Money conviction in ACXP. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
1Q ▲
Buyers last Q
50%

Smart Money Signals — ACXP

Based on 17 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ACXP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🔻

Below peak — only 53% of 3.0Y high

53% of all-time peak
Only 17 funds hold ACXP today versus a peak of 32 funds at 2025 Q2 — just 53% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 29% fewer funds vs a year ago

fund count last 6Q
7 fewer hedge funds hold ACXP compared to a year ago (-29% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟡

Slight buying edge — 50% buying

10 buying10 selling
Last quarter: 10 funds bought or added vs 10 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~7 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 5 → 11 → 3 → 7. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

59% of holders stayed for 2+ years

59% conviction (2yr+) 29% medium 12% new
10 out of 17 hedge funds have held ACXP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +119%, value -99%

Value
-99%
Shares
+118%
Last quarter: funds added +119% more shares while total portfolio value only changed -99%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

7 → 5 → 11 → 3 → 7 new funds/Q
New funds entering each quarter: 5 → 11 → 3 → 7. ACXP is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 59% of holders stayed 2+ years

59% veterans 29% 1-2yr 12% new
Of 17 current holders: 10 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds
7 of 17 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in ACXP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
1.0
out of 10
Low Exit Risk
Exit risk score 1.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ACXP

In 2025 Q4, 10 hedge funds were net buyers of ACXP (7 opened a new position, 3 added to an existing one), while 10 reduced or exited (5 trimmed, 5 sold completely) — a 50% buyer ratio, indicating a slight buying edge. 44% of total institutional value in ACXP is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +2 funds (more new holders than closures). Total institutional holders: 17.

Hedge Fund Ownership: ACXP

How many hedge funds hold ACXP — quarterly history vs. share price
Quarterly hedge fund ownership of ACXP vs. share price

Market Analysis: ACXP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ACXP

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 0 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: ACXP
2026 Q1 Stats Unlock in 9 days 17 + Investors

Track Smart Money conviction in ACXP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 17 16 6.25%
13F Shares 139K 63K 118.74%
Total Value $345K $38M -99.08%
New Positions 7 3 +4
Increased Positions 3 0 +3
Closed Positions 5 21 -16
Reduced Positions 6 13 -7
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ACXP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

17 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ACXP. Verified SEC 13F-HR filings.

Top 11 institutional holders of ACXP — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Prospect Financial Services LLC 0.03% 13,785 $51K
2 Westside Investment Management, Inc. 0.00% 1,650 $6K
3 NBC SECURITIES, INC. 0.00% 1,500 $6K
4 Cambridge Investment Research Advisors, Inc. 0.00% 20,000
5 Cornerstone Planning Group LLC 0.00% 167
6 VANGUARD FIDUCIARY TRUST CO 0.00% 16,205 $60K
7 UBS Group AG 0.00% 6,312 $23K
8 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 31,099 $115K
9 WELLS FARGO & COMPANY/MN 0.00% 2,300 $9K
10 SBI Securities Co., Ltd. 0.00% 6
11 CITIGROUP INC 0.00% 1
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ACURX PHARMACEUTICALS INC (ACXP)

What does the Smart Money Trend signal show for ACXP?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ACXP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ACXP?

Slight buying edge — 50% buying: Last quarter: 10 funds bought or added vs 10 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ACXP holders?

Elite ownership — 44% AUM from top-100 funds: 7 of 17 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in ACXP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ACXP?

59% of holders stayed for 2+ years: 10 out of 17 hedge funds have held ACXP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.